PODESTA GROUP, INC. for GENZYME

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness Lab demonstration issue H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 ESRD "bundling issues" and ESRD drug reimbursement issues

Contacted: SENATE; Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3162 (110th), S. 2029 (110th), H.R. 2606 (110th), H.R. 4 (110th), S. 3101 (110th), H.R. 5480 (110th), H.R. 6331 (110th), S. 1376 (110th), S. 2662 (110th), S. 3 (110th)

Budget/Appropriations BUD

House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution LHHS Appropriations Comparative Effectiveness

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Pharmacy PHA

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Neglected Disease Issues

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 5629 (110th), S. 1695 (110th), H.R. 1956 (110th), S. 4 (110th), S. 623 (110th), H.R. 1038 (110th), S. 596 (110th), S. 1505 (110th), S. 2029 (110th)

Taxation/Internal Revenue Code TAX

Neglected Disease Tax Credit

Contacted: Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007 H R. 1908, Patent Reform Act of 2007

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.R. 1908 (110th), S. 1145 (110th)